Showing results (2341-2350 of 11,104) with videos related to
Sort By:
Pageof 1,111
Journal of Neurology|October 12, 2012
Task-specific dystonias: historical review--a new look at the classicsPedro J Garcia-RuizJournal of Neurology|August 18, 2012
Treatment deviating from guidelines does not influence status epilepticus prognosisAndrea O Rossetti, Vincent Alvarez, Jean-Marie Januel, et al.Journal of Neurology|March 22, 2015
Prevalence of vestibular dysfunction in patients with vestibular schwannoma using video head-impulses and vestibular-evoked potentialsRachael L Taylor, Jonathan Kong, Sean Flanagan, et al.Journal of Neurology|March 22, 2015
Progress in Huntington's disease: the search for markers of disease onset and progressionSarah Mason, Roger A BarkerJournal of Neurology|March 22, 2015
Use of a telestroke service for evaluation of non-stroke neurological casesRené Handschu, Angela Wacker, Mateusz Scibor, et al.Journal of Neurology|March 22, 2015
Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 geneMasayuki Sasaki, Chihiro Ohba, Mizue Iai, et al.Journal of Neurology|August 4, 2021
Anxiety disorders are associated with verbal memory impairment in patients with Parkinson's disease without dementiaNadeeka N Dissanayaka, Elana J Forbes, Ji Hyun J Yang, et al.Journal of Neurology|January 30, 2023
Quality of life, health-related quality of life, and associated factors in Huntington's disease: a systematic reviewPearl J C van Lonkhuizen, Wiebke Frank, Anne-Wil Heemskerk, et al.Journal of Neurology|November 15, 2022
Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectivesPenny Pennington, Bianca Weinstock-Guttman, Channa Kolb, et al.Journal of Neurology|February 3, 2023
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)Maryam Oskoui, John W Day, Nicolas Deconinck, et al.Pageof 1,111